Episode 333 hosts Mike Clague (Nurse Injector from Melbourne, Australia)

In 'The Tox Talks' episodes we feature expert injectors who have significant experience in using botulinum toxins. These episodes explore our guests experiences using particular brands, the evolution of their injecting techniques and we get special insights into the subtle nuances of getting the best out of toxins.

In chapter 11 we talk about Relfydess, a new Botulinum Toxin A manufactured by Galderma.

We first re-introduce Mike (previously on episode 276) and his clinical background. We then cover his involvement in the pre-launch trials using Relfydess and his clinical experience with the product. We covers the efficacy and onset of Relfydess compared to other toxins, its performance in various facial areas, and discuss practical tips for injectors.

00:00 Introduction and Podcast Overview
00:40 Welcome to Chapter 11: The Tox Talks
00:53 Introducing Mike Clague and Relfydess Toxin
01:28 Mike's Background and Experience
03:31 Discussion on Toxin Efficacy and Longevity
06:20 Practical Insights and Injection Techniques
12:53 Patient Experiences and Feedback
24:10 Manufacturing and Purity of Toxins
27:09 Discussion on Antibody Levels
27:44 Patient Reactions to Treatment Onset
28:24 Dosage and Treatment Techniques
31:00 Commercial Implications of Treatment Frequency
32:34 Longevity and Variability of Treatment Effects
42:57 Training and Mentorship in Medical Practice
46:53 Regulations and Compliance in Medical Advertising
50:07 Final Thoughts and Farewell

ALL IA LINKS & CONTACT INFORMATION